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Abstract
Bacteriorhodopsin, found in most halobacteria, is an integral protein that contains
seven transmembrane alpha helices and an organic chromophore, all-trans retinal. Light
energy is captured by the protein and results in a series of spectrally discrete intermediates
that conclude with a proton being pumped across the membrane from the cytoplasmic side to
the extracellular milieu. The most blue-shifted photo-intermediate, the M state, has been of
interest for protein-based holographic memory storage devices. Bacteriorhodopsin mutants
were prepared with either a 4-hydroxy retinal or 3,4-dihydro retinal analog: R82A, R82C,
R82H, R82K, R82N and R82Q. The objective of this research was to investigate the effect
of the combination of genetic and organic modification on the bacteriorhodopsin protein with
respect to the formation and lifetime of the M state. Time-resolved UV-vis spectroscopy of
the 4-hydroxy R82 analogs revealed an enhanced M state, potentially making these R82
analogs an effective candidate for device applications involving holographic memory.
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Introduction
Bacteriorhodopsin is an integral multi-pass protein that is often seen in halobacteria
(such as Halobacterium salinarum), a type of archaea that are found in salt-water
environments. The structure of the protein is a single amino acid chain consisting of 248
amino acids. The chain’s folded secondary structure encompasses seven long transmembrane
alpha helices. The protein is oriented in the cell with the amino terminus at the extracellular
end and the carboxyl terminus at the cytosolic endi1. Figure 1 shows the structure of the
protein.
The main function of the bacteriorhodopsin protein is to pump protons from the
cytoplasmic side to the extracellular milieu, using light energy to fuel the process. Once the
protein absorbs a photon of light energy, an isomerization occurs at a molecule known as
retinal. Retinal is a chromophore that gives the protein its distinct purple color. Furthermore,
the lipid membrane that contains the protein is known as the purple membrane because
bacteriorhodopsin is its only protein constituent. It contains a beta-ionone ring, a polyene
chain containing five carbon-carbon double bonds as well as an aldehyde group at the end of
the polyene chain. The retinal that is observed in the bacteriorhodopsin protein contains all
trans-configured double bonds, which is important to know when discussing the function of
the moleculeii.
The retinal molecule is covalently attached at the Lysine-216 site (via a protonated
Schiff base) in Helix G. The all-trans retinal molecule photo-isomerizes to 13-cis retinal,
which allows the retinal to transfer a proton to the side chain of Aspartate-85, positioned
towards the extracellular side of the celliii. Figure 2 shows the isomerization cycle of the
retinal. The proton is then carried out of the cell through the use of proton release groups,
6

while the negatively charged retinal takes up a proton from another amino side chain,
Aspartate-96, which is positioned closer to the cytosolic side of the cell. The proton travels
using water molecules at each amino acid. Asp-96 is then reprotonated from the cytoplasmiv.
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There are four main intermediates during the photo-cycle at which a photon is
transferred: L, M, N, and O. The L to M state transition occurs as the proton is released from
the Schiff base to Asp-85, which is positioned to release the proton to the extracellular
medium. The actual formation of the M state occurs once the proton is in the extracellular
space. The transition from the M state to the N state occurs as the Schiff base is reprotonated
by Asp-96 at the cytoplasmic side. It has been suggested that the unidirectionality of the
reprotonation of the Schiff base occurs because of the increased proton affinity of Asp-85 in
the M state via the coupling of the proton transfer with the deprotonation. The N to O state
transition follows, in which the retinal molecule re-isomerizes back to the all-trans form, and
Asp-96 is reprotonated by a free proton in the cytoplasmv. There are also other intermediate
forms at different wavelengths, such as K and Lvi. Figure 3 is a diagram that shows the cycle
of intermediates. Figure 4 shows the physical pathway of the proton in the protein.
The M and O states of the bacteriorhodopsin photocycle are crucial for device
applications involving holographic memory and three-dimensional memory, respectively.
The M-state is the most blue-shifted state, while the O state is red-shifted. The O-state,
through the absorption of a photon of red light, enters a branched photocycle that includes the
P1, P2 and Q intermediates. Without red light, the O state transitions back into the resting
state, as seen in Figure 3. Taken together, bacteriorhodopsin has two photocycles (a main one
and a branched one), creating a bi-stable system. This can be used as a possible medium for
information storage for three-dimensional paged memory. Similarly, bacteriorhodopsin has
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been thought of as a possible candidate for holographic device applications based on the
refractivity difference and diffraction efficiency between the resting state and the M State. In
order to achieve optimal conditions for both of these device applications, the lifetime of the
M and O States must be increased together with the yield. Furthermore, the efficiency of the
transition between the O and P States must be increasedvii. This might be accomplished via
modification of the protein via site-directed mutagenesis and by modification to the retinal
chromophore.
Arginine-82 is considered to be involved in the proton release group of
bacteriorhodopsin; however, its exact role in the photocycle is unclear. Previous data
suggested that Arg-82 is the primary counterion in the photocycle. Arg-82 interacts with
Asp-85 and/or Asp-212, perhaps through a salt bridge. The idea that Arg-82 interacts with
Asp-212 is favored, with Arg-82 responding to changes in the protonation state of Asp-85,
Glu-204, or the chromophore. In other words, the movement of Arg-82, whether upwards or
downwards, is a function of the protonation state of the amino side chains it is associated
with, as well as the protonation state of the chromophore. These protonation states define
what intermediate the protein is currently in. For example, in the N intermediate, the Asp-85
and the chromophore are protonated and Glu-204 is deprotonated. This leads to Arg-82
forming a strong interaction with Asp-212, allowing a pathway for the proton to travelviii.
Although this is only one study done to identify the role of Arg-82 in the
bacteriorhodopsin photocycle, it is clear that Arg-82 works towards proton release. Several
studies have looked at the effects of altering the Arg-82 through substituting arginine with
another amino acidix. For example, one study done in a laboratory substituted glutamine and
alanine for arginine and noticed changes in the photocycle, namely that there was no proton
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release in the M statex. The most common mutants of Arg-82 that have been used in
laboratory studies are R82A (substituting alanine), R82C (substituting cysteine), R82Q
(substituting glutamine), R82N (substituting asparagine), and R82K (substituting lysine).
R82K, like wild-type R82A, is positively charged. The other four mutants are either nonpolar or polar/uncharged.
Besides substituting the actual amino acid, another alteration that could potentially
affect the photocycle would be the modification of the retinal, allowing for spectral tuning.
Chromophore modification involves the cleavage of the native retinal in the protein through
photo-induced hydroxylaminolysis. Briefly, the protein is exposed to hydroxylamine under
intense light conditions resulting in the cleavage of the protonated Schiff base linkage and the
formation of a retinal oxime. The retinal oxime is removed from the opsin through a series
of washes with bovine serum albumin. Once the opsin is purified and the retinal oxime is
removed, the altered (synthesized) retinal is incorporatedxi. A few modifications to the
retinal include: an additional double bond in the beta-ionone ring (the A2 reaction), attaching
a keto-group to the carbon-4 position (the 4-keto reaction), and attaching a hydroxyl group to
the 4-carbon position (the 4-hydroxy reaction). Figure 5 shows the reaction scheme for the
synthesis of the A2-retinal, 4-keto retinal and 4-hydroxy retinal analogs.
Modification of the retinal chromophore can result in a shift in the absorption
maximum for the protein, leading to a change in the color of the protein. One laboratory used
A1 and A2 retinal analogs to replace the wild-type retinal in the protein and noticed shifts in
the wavelength for maximum wavelength absorptionxii. Table 1 shows a table of the different
λMax’s for each R82 mutant.

9

Figure 1. 1C3W structure of bacteriorhodopsin. The yellow molecule in the middle of the
protein is the retinal molecule, which isomerizes during light transduction.
(http://guweb2.gonzaga.edu/faculty/cronk/biochem/images/bacteriorhodopsin.jpg)
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Figure 2. The isomerization of all-trans retinal to the 13-cis isomer. The reaction is induced
by light, which causes the retinal to be in a position to transfer a proton to the extracellular
space.
(http://guweb2.gonzaga.edu/faculty/cronk/biochem/images/retinal_isomerization.gif)
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Figure 3. A diagram of the bacteriorhodopsin photocycle, with each intermediate form and
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the wavelength that the intermediate takes place at. At the M state of the photocycle, the
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Deleted: space occurs right near the M
state while

at the N state of the photocycle. (http://www.pnas.org/content/105/3/883/F1.small.gif)

Deleted: t
Deleted: right near

12

Figure 4. The proton pathway in bacteriorhodopsin, with each number representing the steps
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to the proton release. The retinal is included in the diagram, which isomerizes to the 13-cis
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form when the protein is exposed to visible light.
(http://www.bioscience.org/2004/v9/af/1264/fig1.jpg)
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Figure 5. The schematic for modifying 1) the retinal molecule to 2) the A2 retinal via the A2
Deleted: 2

reaction, 3) the 4-hydroxy retinal via the 4-hydroxy reaction and 4) the 4-keto retinal via the
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4-keto reaction. Each modified retinal changes the photophysical properties of the
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bacteriorhodopsin.
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Materials & Methods
Protein preparation: Protein cultures of Halobacterium salinarum strain MPK409 (1 mL)
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were grown from frozen stocks in 5 mL of Culture Medium (CM; 4.28 M NaCl, 81 mM
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MgSO4, 10.2 mM sodium citrate, 26.8 mM KCl, 5 g/L Tryptone, 3 g/L yeast extract, pH 7.2)
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supplemented with 500 µL of uracil stock solution (1.5 mg/mL).
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The cultures were
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incubated for 4-7 days at 40°C with shaking at 200 rpm. Once turbid, 1 mL of the H.
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salinarum strain MPK409 culture was inoculated in 50 mL of CM, and grown for 4-7 days
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under continuous illumination at 40°C with orbital shaking at 200 rpm.

Large-scale

preparation of the mutant protein was then conducted by inoculation of Rich Medium (RM;
4.28 M NaCl, 81 mM MgSO4, 10.2 mM sodium citrate, 26.8 mM KCl, 10 g/L peptone, pH
7.2) supplemented with uracil (100 mg/ 2L RM) with 10 mL of CM culture per RM flask.
Cultures were grown in a 2 L Erlenmeyer flask, containing 1.8 L RM, under continuous
Deleted:

illumination at 40°C with orbital shaking at 200 rpm for 7-10 days.
Formatted: Line spacing: Double

Protein purification. The protein culture was poured into JLA 9.1 tube (1L) and centrifuged
at 5,000 rpm (JLA rotor) for 30 minutes at 4°C. After the clear supernatant was discarded,
the purple pellet was resuspended in 40 mL dH2O and 10 mL of a DNAse stock solution
(0.03 g DNAse, 0.125 g MgSO4, 50 mL ddH2O) was added. The suspension was transferred
to a sterile 250 mL Erlenmeyer flask that was left to shake at 150 rpm overnight at room
temperature. The suspension was then poured into JA-17 tubes and weas centrifuged at 5,000
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rpm in a Beckman Ultracentrifuge (JA-17 rotor) for 10 minutes at 4˚ C. The white pellet was
discarded and the purple supernatant was poured into Ti-45 tubes, which were then
centrifuged at 32,000 rpm in a Beckman Ultracentrifuge (45-Ti rotor) for 35 minutes at 4 °C;
afterwards, the supernatant was discarded and the purple pellet was resuspended in dH2O,
making sure to avoid resuspending the white debris located at the center of the pellet. This
process was repeated until the supernatant layer was colorless and the white debris in the
center of the pellet was no bigger than 5 mm in diameter (approximately 4-5 spins). The
pellet should only contain fragments of the purple membrane in which the protein is
embedded in. The purified protein was resuspended in a minimal amount (5 – 10 mL) of
Formatted: Font: Not Italic

dH2O, transferred to a sterile falcon tube, and stored at 4 °C.
Protein quantification. Protein quantification was done using Beer’s Law, which follows the
formula, A = ε b c, where A is the absorbance (based on the readings from the UV-Vis), ε is
the molar absorptivity (63,000 L/mol*cm), b is the path length (1 cm) and c is the
concentration (what is being determined). Once the concentration was determined by using
this equation, it had to be converted from mol/L to mg/mL using unit conversions. The
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molecular weight of BR is 26,000 g/mol. The concentration was multiplied by the molecular
weight and the units were changed to mg/mL.
Absorption spectroscopy: All spectra were collected with a Varian Cary-50 UV-Vis
spectrophotometer (Palo Alta, CA). Measurements were conducted in either distilled water
or 10 mM TAPS (N-tris[hydroxymethyl]methyl-3-aminopropanesulfonic acid sodium salt)
(pH 8.5) at ambient temperature.
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Bleaching procedure: Fragments of the purple membrane (containing the protein) were
pelleted in a tabletop centrifuge using a TLA 55 rotor (20 minutes, 50,000 rpm, 4°C). The
pelleted protein was resuspended in 10 mM TAPS, pH 8.5, containing 1 M NH2OH-HCl to
yield a final protein concentration of 1.5 mg/mL. The sample was illuminated at room
temperature with an in house protein illuminator constructed using Amber LEDs. During the
bleaching process, the retinal is converted to a retinal oxime and can be observed
spectroscopically by the appearance of a 360 nm peak. Once the conversion was complete,
observed spectroscopically by the disappearance of the 570 nm peak, the apo-protein was
pelleted and purified by a series of 10mM TAPS washes to remove the hydroxylamine
solution. The retinal oxime was removed by a series of 2% BSA (Bovine Serum Albumin) in
50mM TAPS (pH 8.5) washes with a one hour incubation period at 4°C between spins.
Lastly, the BSA solution is removed by a series of 10mM TAPS washes.

Reconstitution of retinal analog into bacteriorhodopsin: The retinal analog, dissolved in a
minimal amount of ethanol, was added to the apo-protein in 2-4 molar excess. Regeneration
of the bacteriorhodopsin protein was observed spectroscopically by the appearance of the 570
nm peak. Regeneration times vary with the protein mutant and are typically less than 24
hours. The excess retinal analog was removed by a series of 2% BSA washes (typically 4-5)
with a one-hour incubation time at 4°C between spins. The BSA was removed by a series of
10mM TAPS washes (typically 4-5). For Wild-Type BR samples, the TAPS solution was
removed by two washes with water. Mutant BR samples were stored in the 10mM TAPS
buffer at 4°C.
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General: The 1H NMR spectra were recorded on a Bruker 400 NMR spectrometer using
tetramethylsilane (TMS, δ 0 ppm) as the internal standard. All syntheses were carried out
under a nitrogen atmosphere. N-bromosuccinimide (NBS) was recrystallized using distilled
H2O. Pet. ether refers to low boiling petroleum ether 40-60 °C. Unless otherwise stated,
purification was performed by flash column chromatography (Dynamic Adsorbents flash
silica gel) using pet. ether/ ethyl acetate mixtures.

The progress of the reactions was

monitored by thin layer chromatography (TLC) with a 3:1 ratio of pet. ether/ethyl acetate
using 0.25 mm precoated silica gel plates, which were visualized by ultraviolet light and
stained with phosphomolybdic acid (PMA). Tetrahydrofuran (THF), diethyl ether (Et2O) and
N,N-dimethylformamide (DMF) were used without further purification unless otherwise
stated.

A2-retinal (2): To a stirred solution of all-trans retinal (100 mg, 0.35 mmol) in anhydrous
THF (9 mL) at 0°C under dim red light, a solution of N-bromosuccinimide (100 mg, 0.56
mmol) was added in anhydrous THF (4 mL) dropwise. The reaction mixture was allowed to
stir at 0°C for 30 minutes, then a mixture of potassium fluoride (100 mg, 1.72 mmol) in 20
mL DMF was added. The reaction mixture was allowed to stir for 24 hours at room
temperature in darkness. After 24 hours, the reaction mixture was quenched by the dropwise
addition of saturated sodium bicarbonate solution (10 mL) and let to stir at room temperature
for 30 minutes. The resulting mixture was extracted with diethyl ether (3 x 20 mL). The
organic layers were combined and washed with distilled water until neutrality was reached (3
x 20 mL).

The organic fraction was then dried (NaSO4), filtered, and concentrated under

reduced pressure. The resulting residue was purified by flash column chromatography to
give A2-retinal (2).
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4-hydroxy retinal (3): To a stirred solution of all-trans retinal (100 mg, 0.35 mmol) in a
mixture of acetonitrile (15 mL), dichloromethane (1.0 mL), and distilled water (100 µL) was
added N-bromosuccinimide (0.35 mmol) at -15°C. The reaction mixture was let to stir for 20
minutes under dim red light. After 20 minutes, N,N-diethylaniline (100 µL) was added. The
reaction mixture was stirred at 0°C for 20 minutes, then poured into 5% aqueous Na2S2O3
solution and extracted with diethyl ether (3 x 15 mL). The combined organic layers were
washed with 1 M aqueous HCl solution (10 mL), H2O (10 mL) and saturated NaCl solution
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(10 mL), respectively.

The organic fraction was then dried (MgSO4), filtered, and

concentrated under reduced pressure. The resulting residue was purified by flash column
chromatography to give 4-hydroxy retinal (3).

4-keto retinal (4): To a stirred solution of all-trans retinal (100 mg, 0.35 mmol) in THF (9
mL) at 0°C under dim red light was added a solution of N-bromosuccinimide (100 mg, 0.56
mmol) in THF (4 mL) dropwise. Benzoyl peroxide (0.5 mg) was then added to the reaction
flask. The reaction mixture was let to stir at 0°C for 2 hours, then a mixture of potassium
fluoride (100 mg, 1.72 mmol) in DMF (20 mL) was added. The reaction mixture was let to
stir overnight at room temperature in darkness. After 24 hours, the reaction mixture was
quenched by the dropwise addition of saturated sodium bicarbonate solution (10 mL) and let
to stir at room temperature for 30 minutes. The resulting mixture was extracted with diethyl
ether (3 x 20 mL). The organic layers were combined and washed with distilled water until
neutrality was reached (3 x 20 mL). The organic fraction was then dried (NaSO4), filtered,
and concentrated under reduced pressure. The resulting residue was purified by flash column
chromatography to give 4-keto retinal (4).
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Time-Resolved UV-Vis Spectroscopy: Time-resolved kinetics experiments were performed
with the protein analogs at room-temperature suspended in either distilled water (pH 6.8) or
10mM TAPS (pH 8.5). The protein analogs were in 1-cm path length plastic fluorescence
cuvettes, covered with caps. The samples were exposed to 532-nm, 3.3-ns pulse-width
emission from an optical parametric oscillator (OPO) pumped by the third harmonic of a
Neodymium:YAG laser system (Coherent Infinity-XPO). The energy of each pulse was
measured by a calibrated energy meter (Ophir PE50-BB) interfaced with an Ophir Laserstar
acquisition unit. A rapid- scanning monochromator (RSM) system (OLIS Instruments, Inc.
RSM-1000 stopped flow) collected spectra of these samples orthogonal to the incident beam.
The range of the spectra was from 360 to 740 nm. The RSM system monitored the difference
spectrum, with 1000 scans averaged per second.
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Results and Discussion
Table 1: Absorption maximum of R82 analogs.
Protein
H2O
DA λmax (nm) LA λmax (nm)
WT-BR
558.9
570.0
A2 WT-BR
592.0
598.0
4-hydroxy WT-BR 538.1
545.9

TAPS, pH 8.5
DA λmax (nm)
561.0
594.0
538.1

LA λmax (nm)
568.9
601.0
542.9

R82A
A2 R82A
4-hydroxy R82A

574.0
N/A
N/A

574.0
N/A
N/A

565.1
581.0
528.0

561.9
593.0
536.1

R82C
A2 R82C
4-hydroxy R82C

596.9
N/A
N/A

594.9
N/A
N/A

566.0
N/A
N/A

565.1
N/A
N/A

R82H
A2 R82H
4-hydroxy R82H

568.1
589.1
543.0

568.1
589.1
543.0

571.9
596.9
541.1

566.0
599.1
545.0

R82K
A2 R82K
4-hydroxy R82K

552.0
584.0
529.0

552.0
584.0
529.0

552.9
585.1
541.1

561.9
585.0
527.9

R82N
A2 R82N
4-hydroxy R82N

561.0
589.1
543.0

561.0
589.1
543.0

N/A
587.0
541.1

N/A
599.1
545.0

R82Q
A2 R82Q
4-hydroxy R82Q

580.0
N/A
N/A

580.0
N/A
N/A

566.0
N/A
N/A

566.0
N/A
N/A
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Figure 6. Time resolved difference spectra of wild-type BR (top), A2 BR (center) and 4hydroxy BR (bottom). The measurements were recorded on samples in H2O (left column)
and pH = 8.5 (right column) at 25°C showing the formation of M-state (~400nm) and O-state
(~640nm).
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Figure 7. Time resolved difference spectra of R82A (top), 4-hydroxy R82A (center) and A2
R82A (bottom). The measurements were recorded on samples in H2O (left column) and pH
= 8.5 (right column) at 25°C showing the formation of M-state (~400nm) and O-state
(~640nm).
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Figure 8. Time resolved difference spectra of R82C (top), 4-hydroxy R82C (center) and A2
R82C (bottom). The measurements were recorded on samples in H2O at 25°C showing the
formation of M-state (~400nm) and O-state (~640nm).
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Figure 9. Time resolved difference spectra of R82H (top), 4-hydroxy R82H (center) and A2
R82H (bottom). The measurements were recorded on samples in H2O (left column) and pH
= 8.5 (right column) at 25°C showing the formation of M-state (~400nm) and O-state
(~640nm).
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Figure 10. Time resolved difference spectra of R82K (top), 4-hydroxy R82K (center) and A2
R82K (bottom). The measurements were recorded on samples in H2O (left column) and pH
= 8.5 (right column) at 25°C showing the formation of M-state (~400nm) and O-state
(~640nm).
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Figure 11. Time resolved difference spectra of R82Q (top), 4-hydroxy R82Q (center) and A2
R82Q (bottom). The measurements were recorded on samples in H2O at 25°C showing the
formation of M-state (~400nm) and O-state (~640nm).
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Wild-Type BR: The λmax of WT-BR was measured in both distilled water (pH 6.8) and 10
mM TAPS buffer (pH 8.5) in both light and dark adaptations. Amongst the WT-BR analogs,
the most red-shifted was A2 BR. As observed in the time-resolved difference spectra data for
only the WT-BR analogs, the O State that is most red-shifted is also seen in A2 BR in both
distilled water and TAPS. Normally, the O State is present at around 640 nm, but in the case
Comment [H16]: This is repetitive
with “also”.

of A2 BR, the O State was observed around 660 nm. Its M State was also red-shifted by
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about 20 nm. In comparison to WT-BR, the A2 analog had a shorter O state, as seen in both
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distilled water and TAPS, while the 4-hydroxy BR analog barely showed any O state at all.

Deleted: fairly shorter

The 4-hydroxy BR presented a blue-shifted λmax, as well as a blue-shifted M and O state.

R82 Analogs: Looking at Table 2, the λmax’s, of the R82 mutants and their A2 counterparts
were all red-shifted. The A2 mutants were more red-shifted than the unmodified R82
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analogs. Meanwhile, all of the 4-hydroxy mutants of the R82 analogs were blue-shifted in
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comparison to WT-BR. Furthermore, the greater red-shift and blue-shift occurred in TAPS as
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opposed to distilled water. The greatest red-shift occurred in A2 R82H in TAPS (40 nm)
Deleted: s

while the greatest blue-shift occurred in 4-Hydroxy R82A (30 nm).
Most of the analogs presented a very small amount of O state. If there was an O State,
it was fairly short-lived, such as with the 4-Hydroxy R82A sample. A minimal amount of
short-lived O state was also observed in R82K, R82H, and 4-hydroxy R82H (the R82H
analogs were only seen to have an O State in distilled water). Besides the 4-hydroxy R82A
sample being significantly blue-shifted, the O States for the samples that presented it had the
O State occur at its usual wavelength around 640 nm.
Almost all of the samples displayed an M State in both distilled water and TAPS,
although some more than others and some for a longer amount of times than others. The
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exception is R82C, R82Q and its respective mutants. This is because these analogs tend to
die quickly and the modified retinals did not incorporate properly. The M State occurred at
its normal wavelength of 400 nm for all the samples, except for A2 R82K and A2 R82A,
which were both slightly red-shifted by about 20 nm. The longest-lived M States occurred in
the 4-Hydroxy R82 samples, especially 4-Hydroxy R82K, which appears to have the longest
M state. The 4-Hydroxy R82 analogs presented longer M states than the M states of the 4Hydroxy BR.
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Conclusion

Deleted: Conclusions/Future Work

Although more research needs to be done, it appears that despite the minimal amount of O
State, the protein is photocycling in some of the R82 analogs. This means that there is a
possibility that the samples are actively pumping protons. However, there is also a good
chance that protein returns to its resting state after the M state, which explains the lack of O
state formation. In terms of device application, it appears that these analogs would not be an
effective candidate for three-dimensional paged memory, since the O State is not very
enhanced and would probably not go into the branched P1 and P2 states. Furthermore, two of
the criteria for three-dimensional paged memory are a longer life span and a greater yield of
the O State, which none of the analogs seem to express.
The analogs that displayed a slightly enhanced M State could potentially be an
effective candidate for holographic memory, since the criteria require both a greater M State
life span and a greater yield of the M State.
Future work for this project includes retrieving more time-resolved spectroscopy and
UV-Vis spectroscopy data, including the analogs that are missing from the results (such as
time-resolved spectra data on R82N). Furthermore, time-resolved spectra difference data and
UV-Vis light/data dark adaptation data on samples suspended in both a phosphate buffer (pH
7.0) and a 2-(N-morpholino)ethanesulfonic acid (MES) buffer (pH 5.5) would be useful to
have. Finally, data on samples with an incorporated 4-keto retinal would be beneficial in
adding any new insight. These two additions to the research could possibly display some
enhanced M States and O States that would be useful for device application.
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